Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Jones

Showing results (191-200 of 531) with videos related to

Pageof 54
Sort By:
Australia and New Zealand Health Policy|April 21, 2005
Routine measurement of outcomes in Australia's public sector mental health servicesJane Pirkis, Philip Burgess, Tim Coombs, et al.
Journal of Patient-Reported Outcomes|January 16, 2019
Development and adaptation of patient-reported outcome measures for patients who experience itch associated with primary biliary cholangitisMona L Martin, Larissa Stassek, Steven I Blum, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 17, 2006
Utility of serum Campylobacter specific antibodies in determining prior Campylobacter infection in neurological diseaseBruce V Taylor, Jan Williamson, David Jones, et al.
Drugs - Real World Outcomes|September 21, 2023
Treatment Patterns by Race and Ethnicity in Newly Diagnosed Persons with Multiple SclerosisCaroline Kelley Geiger, Daniel Sheinson, Tu My To, et al.
Neurology and Therapy|July 17, 2023
Real-World Clinical and Economic Outcomes Among Persons With Multiple Sclerosis Initiating First- Versus Second- or Later-Line Treatment With OcrelizumabCaroline K Geiger, Danny Sheinson, Tu My To, et al.
Medicine, Science, and the Law|January 1, 2015
Development of a computational biomechanical infant model for the investigation of infant head injury by shakingMichael David Jones, Philip S Martin, Jonathan M Williams, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|March 3, 2009
Colorectal cancer patients' attitudes towards involvement in decision makingKinta Beaver, Malcolm Campbell, Olive Craven, et al.
Quality & Safety in Health Care|October 5, 2007
Primary healthcare teams' views on using mortality data to review clinical policiesEmma Sullivan, Richard Baker, David Jones, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 15, 2023
Setanaxib, a first-in-class selective NADPH oxidase 1/4 inhibitor for primary biliary cholangitis: A randomized, placebo-controlled, phase 2 trialPietro Invernizzi, Marco Carbone, David Jones, et al.
Annals of Surgical Oncology|January 7, 2003
Accuracy of 11-gauge vacuum-assisted core biopsy of mammographic breast lesionsSteven Pandelidis, David Heiland, David Jones, et al.
Pageof 54

Showing results (191-200 of 531) with videos related to

Sort By:
Pageof 54
Australia and New Zealand Health Policy|April 21, 2005
Routine measurement of outcomes in Australia's public sector mental health servicesJane Pirkis, Philip Burgess, Tim Coombs, et al.
Journal of Patient-Reported Outcomes|January 16, 2019
Development and adaptation of patient-reported outcome measures for patients who experience itch associated with primary biliary cholangitisMona L Martin, Larissa Stassek, Steven I Blum, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 17, 2006
Utility of serum Campylobacter specific antibodies in determining prior Campylobacter infection in neurological diseaseBruce V Taylor, Jan Williamson, David Jones, et al.
Drugs - Real World Outcomes|September 21, 2023
Treatment Patterns by Race and Ethnicity in Newly Diagnosed Persons with Multiple SclerosisCaroline Kelley Geiger, Daniel Sheinson, Tu My To, et al.
Neurology and Therapy|July 17, 2023
Real-World Clinical and Economic Outcomes Among Persons With Multiple Sclerosis Initiating First- Versus Second- or Later-Line Treatment With OcrelizumabCaroline K Geiger, Danny Sheinson, Tu My To, et al.
Medicine, Science, and the Law|January 1, 2015
Development of a computational biomechanical infant model for the investigation of infant head injury by shakingMichael David Jones, Philip S Martin, Jonathan M Williams, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|March 3, 2009
Colorectal cancer patients' attitudes towards involvement in decision makingKinta Beaver, Malcolm Campbell, Olive Craven, et al.
Quality & Safety in Health Care|October 5, 2007
Primary healthcare teams' views on using mortality data to review clinical policiesEmma Sullivan, Richard Baker, David Jones, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 15, 2023
Setanaxib, a first-in-class selective NADPH oxidase 1/4 inhibitor for primary biliary cholangitis: A randomized, placebo-controlled, phase 2 trialPietro Invernizzi, Marco Carbone, David Jones, et al.
Annals of Surgical Oncology|January 7, 2003
Accuracy of 11-gauge vacuum-assisted core biopsy of mammographic breast lesionsSteven Pandelidis, David Heiland, David Jones, et al.
Pageof 54